ICALZISS
Live / Applied — Second extension granted (statement of use) (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 19 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98410372
- Mark type
- Stylized text
- Filed
- 19 Feb 2024
- Published for opposition
- 10 Sept 2024
- Attorney of record
- KATHERINE ALLOR
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration
Owner
- GAMBRO LUNDIA AB, Lund, SE
- GAMBRO LUNDIA AB, Lund, SE
Prosecution history
- 30 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2025 — SOU EXTENSION 2 GRANTED
- 29 Oct 2025 — SOU EXTENSION 2 FILED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2025 — SOU EXTENSION 1 GRANTED
- 02 May 2025 — SOU EXTENSION 1 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Aug 2024 — ASSIGNED TO EXAMINER
- 24 Jun 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED